DOCSLIB.ORG

Protein Phosphatase 2A, Complement Component 4, and APOE Genotype Linked To

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Protein Phosphatase 2A, Complement Component 4, and APOE Genotype Linked To medRxiv preprint doi: https://doi.org/10.1101/2020.11.20.20235051; this version posted November 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Protein phosphatase 2A, complement component 4, and APOE genotype linked to Alzheimer’s disease using a systems biology approach Gyungah R. Jun1,2,8,*, Yang You5, Congcong Zhu1, Gaoyuan Meng10, Jaeyoon Chung1, Rebecca Panitch1, Junming Hu1, Weiming Xia5,10, The Alzheimer’s Disease Genetics Consortium, David A. Bennett11, Tatiana M. Foroud12, Li-San Wang13, Jonathan L. Haines14, Richard Mayeux15, Margaret A. Pericak-Vance16, Gerard D. Schellenberg13, Rhoda Au3,6,9, Kathryn L. Lunetta8, Tsuneya Ikezu3,5,7, Thor D. Stein4,10, Lindsay A. Farrer1,2,3,8,9,* Departments of 1Medicine (Biomedical Genetics), 2Ophthalmology, 3Neurology, 4Pathology & Laboratory Medicine, 5Pharmacology & Experimental Therapeutics,6Anatomy & Neurobiology, and7Center for Systems Neuroscience, Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118, USA. Departments of 8Biostatistics and 9Epidemiology, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA. 10Department of Veterans Affairs Medical Center, Bedford, MA 01730, USA. 11Rush Alzheimer’s Disease Center, Rush University Medical Center, 1750 W. Harrison Street, Suite 1000, Chicago, IL 60612, USA. 12Department of Medical and Molecular Genetics, Indiana University, 410 W 10th Street, Indianapolis, IN 46202, USA. 13Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. 1 NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.11.20.20235051; this version posted November 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . 14Department of Population & Quantitative Health Sciences, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106, USA. 15Taub Institute on Alzheimer's Disease and the Aging Brain, Gertrude H. Sergievsky Center Department of Neurology, Columbia University, 710 West 168th Street, New York, NY 10032, USA. 16John P. Hussman Institute for Human Genomics, Department of Human Genetics, and Dr. John T. Macdonald Foundation, University of Miami, 1501 NW 10th Ave, Miami, FL 33136, USA. * To whom correspondence should be addressed Gyungah R. Jun, PhD, Department of Medicine (Biomedical Genetics), Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118, USA 02118, email: [email protected]; Lindsay A. Farrer, PhD, Department of Medicine (Biomedical Genetics), Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118, USA 02118, email: [email protected]. 2 medRxiv preprint doi: https://doi.org/10.1101/2020.11.20.20235051; this version posted November 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . ABSTRACT Background: Recent reports suggest that the rare apolipoprotein E (APOE) Christchurch mutation and ɛ2 allele protect against Alzheimer’s disease (AD) pathology by reducing the burden of tau pathology. However, the mechanism(s) underlying the ɛ2 protective effect linking to tau is largely unknown. Methods: The role of the ɛ2 allele in Alzheimer’s disease (AD) was investigated a genome-wide association study (GWAS) for AD among 2,120 ɛ2 carriers from the Alzheimer Disease Genetics Consortium (ADGC), and then prioritized by gene network analysis, differential gene expression analysis at tissue- and cell-levels as well as methylation profiling of CpG sites, in prefrontal cortex tissue from 761 brains of the Religious Orders Study and Memory and Aging Project (ROSMAP) and the Framingham Heart Study (FHS), Boston University Alzheimer’s Disease Center (BUADC). The levels of two catalytic subunit proteins from protein phosphatase 2A (PPP2CA and PPP2CB) were validated in prefrontal cortex area of 193 of the FHS/BUADC brains. The findings from human autopsied brains were further validated by a co-culture experiment of human isogenic APOE induced pluripotent stem cell (iPSC) derived neurons and astrocytes. Results: Of the significantly associated loci with AD among APOE ɛ2 carriers (P<10-6), PPP2CB (P=1.1x10-7) was the key node in the APOE ɛ2-related gene network and contained the most significant CpG site (P=7.3x10-4) located 2,814 base pair upstream of the top-ranked GWAS variant. Among APOE ɛ3/ɛ4 subjects, the level of Aβ42 was negatively correlated with protein levels of PPP2CA (P=9.9x10-3) and PPP2CB (P=2.4x10-3), and PPP2CA level was correlated with the level of pTau231 level (P=5.3x10-3). Significant correlations were also observed for PPP2CB with complement 4B (C4B) protein levels (P=3.3x10-7) and PPP2CA with cross reactive protein -4 (CRP) levels (P=6.4x10 ). C1q level was not associated with Aβ42, pTau231, PPP2CB, or C4B 3 medRxiv preprint doi: https://doi.org/10.1101/2020.11.20.20235051; this version posted November 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . levels. We confirmed the significant correlation of PPP2CB expression with pTau231/tTau ratio (P=0.01) and C4A/B (P=2.0x10-4) expression observed in brain tissue in a co-culture experiment of iPSC derived neurons and astrocytes. Conclusion: We demonstrated for the first time a molecular link between a tau phosphatase and the classical complement pathway, especially C4, and AD-related tau pathology. Key words: Alzheimer disease, APOE genotype, PPP2CB, complement component 4B, tau pathology 4 medRxiv preprint doi: https://doi.org/10.1101/2020.11.20.20235051; this version posted November 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . BACKGROUND Alzheimer disease (AD) is a progressive neurodegenerative disorder and accounts for 60-80% of all causes of dementia. None of the prescribed medications for symptomatic treatment of AD retard or stop neuronal degeneration [1]. AD currently affects about 5.8 million Americans age 65 and older and will increase to 13.8 million by 2050 if current trends continue [1]. AD is the sixth leading cause of death in the United States and its mortality rate increased 146% between 2000 and 2018 [1]. More than 16 million caregivers provided about 18.6 billion hours of care (valued around $244 billion) to people with AD or other dementias in 2019, and total health care payments in 2020 for people age 65 and older with dementia are estimated to be $305 billion [1]. Apolipoprotein E (APOE) genotype is the strongest risk factor for the common form of AD that occurs after age 65 years [1]. Combinations of amino acid residues at 112 (rs429358) and 158 (rs7412) determine three common APOE alleles (ɛ2, ɛ3 and ɛ4), where ɛ4 increases but ɛ2 decreases AD risk [2, 3]. Lifetime risk of AD among female ɛ4 homozygotes is approximately 60% and 10 times higher than for ɛ2 carriers matched for sex and age [2, 3]. Neuropathological hallmarks of AD are neurofibrillary tangles consisting of decomposed microtubules and phosphorylated tau (p-tau) and neuritic plaques containing toxic beta-amyloid peptides (Aβ) [1]. Frequencies of APOE ɛ2/2, ɛ3/3 and ɛ4/4 homozygotes among non-Hispanic whites are about 0.5%, 38.2%, and 12.6%, respectively [3, 4]. Odds ratios of AD among clinically and neuropathologically confirmed ɛ4 and ɛ2 homozygotes in this group are approximately 31 and 0.13, respectively, compared to persons with the common ɛ3/ɛ3 genotype [5]. Common variants in the region of MAPT (the gene encoding tau protein) have been associated with AD among individuals who lack ɛ4 [6]. The protective effect of ɛ2 on tangle burden is independent from that on plaque burden and specific to AD pathology [5]. An exaggerated modifying effect of APOE 5 medRxiv preprint doi: https://doi.org/10.1101/2020.11.20.20235051; this version posted November 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . alleles on clinical and pathological manifestations of AD was demonstrated by the recent discovery of the rare APOE Christchurch (APOEch) mutation on a ɛ3 chromosome background in a carrier of the deleterious presenilin 1 (PSEN1) E280A mutation that causes early onset AD typically between ages 30 and 60 among members of a large kindred with autosomal dominant AD. Notably, the E280A mutation carrier who was homozygous for the APOEch variant had hyperlipoproteinemia Type III that is typically associated with ɛ2 homozygosity, presented with delayed cognitive impairment in her seventies, and showed profound plaque burden but limited neurofibrillary tangle involvement by positron emission tomography (PET) imaging [7]. In fact, accumulation of tau protein (the primary constituent of tangles) measured by PET is strongly associated with memory decline and most prominent in the medial temporal lobe [8].
Load more

Recommended publications
  • Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
    Leukemia (2010) 24, 756–764 & 2010 Macmillan Publishers Limited All rights reserved 0887-6924/10 $32.00 www.nature.com/leu ORIGINAL ARTICLE Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells A Pellagatti1, M Cazzola2, A Giagounidis3, J Perry1, L Malcovati2, MG Della Porta2,MJa¨dersten4, S Killick5, A Verma6, CJ Norbury7, E Hellstro¨m-Lindberg4, JS Wainscoat1 and J Boultwood1 1LRF Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, UK; 2Department of Hematology Oncology, University of Pavia Medical School, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 3Medizinische Klinik II, St Johannes Hospital, Duisburg, Germany; 4Division of Hematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 5Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK; 6Albert Einstein College of Medicine, Bronx, NY, USA and 7Sir William Dunn School of Pathology, University of Oxford, Oxford, UK To gain insight into the molecular pathogenesis of the the World Health Organization.6,7 Patients with refractory myelodysplastic syndromes (MDS), we performed global gene anemia (RA) with or without ringed sideroblasts, according to expression profiling and pathway analysis on the hemato- poietic stem cells (HSC) of 183 MDS patients as compared with the the French–American–British classification, were subdivided HSC of 17 healthy controls. The most significantly deregulated based on the presence or absence of multilineage dysplasia. In pathways in MDS include interferon signaling, thrombopoietin addition, patients with RA with excess blasts (RAEB) were signaling and the Wnt pathways. Among the most signifi- subdivided into two categories, RAEB1 and RAEB2, based on the cantly deregulated gene pathways in early MDS are immuno- percentage of bone marrow blasts.
    [Show full text]
  • Psychostimulant-Regulated Plasticity in Interneurons of the Nucleus Accumbens
    Psychostimulant-Regulated Plasticity in Interneurons of the Nucleus Accumbens by David A. Gallegos Department of Neurobiology Duke University Date:_______________________ Approved: ___________________________ Anne E. West, Supervisor ___________________________ Jorg Grandl ___________________________ Debra Silver ___________________________ Gregory Crawford ___________________________ Hiro Matsunami Psychostimulant-Regulated Epigenetic Plasticity in Interneurons of the Nucleus Accumbens submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Neurobiology in the Graduate School of Duke University 2019 ABSTRACT Psychostimulant-Regulated Epigenetic Plasticity in Interneurons of the Nucleus Accumbens by David A. Gallegos Department of Neurobiology Duke University Date:_______________________ Approved: ___________________________ Anne E. West, Supervisor ___________________________ Jorg Grandl ___________________________ Debra Silver ___________________________ Gregory Crawford ___________________________ Hiro Matsunami An abstract of a dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Neurobiology in the Graduate School of Duke University 2019 Copyright by David Andres Gallegos 2019 Abstract Exposure to psychostimulant drugs of abuse exerts lasting influences on brain function via the regulation of immediate and persistent gene transcription. These changes in gene transcription drive the development of addictive-like
    [Show full text]
  • 1 Supporting Information for a Microrna Network Regulates
    Supporting Information for A microRNA Network Regulates Expression and Biosynthesis of CFTR and CFTR-ΔF508 Shyam Ramachandrana,b, Philip H. Karpc, Peng Jiangc, Lynda S. Ostedgaardc, Amy E. Walza, John T. Fishere, Shaf Keshavjeeh, Kim A. Lennoxi, Ashley M. Jacobii, Scott D. Rosei, Mark A. Behlkei, Michael J. Welshb,c,d,g, Yi Xingb,c,f, Paul B. McCray Jr.a,b,c Author Affiliations: Department of Pediatricsa, Interdisciplinary Program in Geneticsb, Departments of Internal Medicinec, Molecular Physiology and Biophysicsd, Anatomy and Cell Biologye, Biomedical Engineeringf, Howard Hughes Medical Instituteg, Carver College of Medicine, University of Iowa, Iowa City, IA-52242 Division of Thoracic Surgeryh, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada-M5G 2C4 Integrated DNA Technologiesi, Coralville, IA-52241 To whom correspondence should be addressed: Email: [email protected] (M.J.W.); yi- [email protected] (Y.X.); Email: [email protected] (P.B.M.) This PDF file includes: Materials and Methods References Fig. S1. miR-138 regulates SIN3A in a dose-dependent and site-specific manner. Fig. S2. miR-138 regulates endogenous SIN3A protein expression. Fig. S3. miR-138 regulates endogenous CFTR protein expression in Calu-3 cells. Fig. S4. miR-138 regulates endogenous CFTR protein expression in primary human airway epithelia. Fig. S5. miR-138 regulates CFTR expression in HeLa cells. Fig. S6. miR-138 regulates CFTR expression in HEK293T cells. Fig. S7. HeLa cells exhibit CFTR channel activity. Fig. S8. miR-138 improves CFTR processing. Fig. S9. miR-138 improves CFTR-ΔF508 processing. Fig. S10. SIN3A inhibition yields partial rescue of Cl- transport in CF epithelia.
    [Show full text]
  • Molecular Effects of Isoflavone Supplementation Human Intervention Studies and Quantitative Models for Risk Assessment
    Molecular effects of isoflavone supplementation Human intervention studies and quantitative models for risk assessment Vera van der Velpen Thesis committee Promotors Prof. Dr Pieter van ‘t Veer Professor of Nutritional Epidemiology Wageningen University Prof. Dr Evert G. Schouten Emeritus Professor of Epidemiology and Prevention Wageningen University Co-promotors Dr Anouk Geelen Assistant professor, Division of Human Nutrition Wageningen University Dr Lydia A. Afman Assistant professor, Division of Human Nutrition Wageningen University Other members Prof. Dr Jaap Keijer, Wageningen University Dr Hubert P.J.M. Noteborn, Netherlands Food en Consumer Product Safety Authority Prof. Dr Yvonne T. van der Schouw, UMC Utrecht Dr Wendy L. Hall, King’s College London This research was conducted under the auspices of the Graduate School VLAG (Advanced studies in Food Technology, Agrobiotechnology, Nutrition and Health Sciences). Molecular effects of isoflavone supplementation Human intervention studies and quantitative models for risk assessment Vera van der Velpen Thesis submitted in fulfilment of the requirements for the degree of doctor at Wageningen University by the authority of the Rector Magnificus Prof. Dr M.J. Kropff, in the presence of the Thesis Committee appointed by the Academic Board to be defended in public on Friday 20 June 2014 at 13.30 p.m. in the Aula. Vera van der Velpen Molecular effects of isoflavone supplementation: Human intervention studies and quantitative models for risk assessment 154 pages PhD thesis, Wageningen University, Wageningen, NL (2014) With references, with summaries in Dutch and English ISBN: 978-94-6173-952-0 ABSTRact Background: Risk assessment can potentially be improved by closely linked experiments in the disciplines of epidemiology and toxicology.
    [Show full text]
  • CSE642 Final Version
    Eindhoven University of Technology MASTER Dimensionality reduction of gene expression data Arts, S. Award date: 2018 Link to publication Disclaimer This document contains a student thesis (bachelor's or master's), as authored by a student at Eindhoven University of Technology. Student theses are made available in the TU/e repository upon obtaining the required degree. The grade received is not published on the document as presented in the repository. The required complexity or quality of research of student theses may vary by program, and the required minimum study period may vary in duration. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain Eindhoven University of Technology MASTER THESIS Dimensionality Reduction of Gene Expression Data Author: S. (Sako) Arts Daily Supervisor: dr. V. (Vlado) Menkovski Graduation Committee: dr. V. (Vlado) Menkovski dr. D.C. (Decebal) Mocanu dr. N. (Nikolay) Yakovets May 16, 2018 v1.0 Abstract The focus of this thesis is dimensionality reduction of gene expression data. I propose and test a framework that deploys linear prediction algorithms resulting in a reduced set of selected genes relevant to a specified case. Abstract In cancer research there is a large need to automate parts of the process of diagnosis, this is mainly to reduce cost, make it faster and more accurate.
    [Show full text]
  • Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen
    CLINICAL RESEARCH www.jasn.org Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen Rany M. Salem ,1 Jennifer N. Todd,2,3,4 Niina Sandholm ,5,6,7 Joanne B. Cole ,2,3,4 Wei-Min Chen,8 Darrell Andrews,9 Marcus G. Pezzolesi,10 Paul M. McKeigue,11 Linda T. Hiraki,12 Chengxiang Qiu,13 Viji Nair,14 Chen Di Liao,12 Jing Jing Cao,12 Erkka Valo ,5,6,7 Suna Onengut-Gumuscu,8 Adam M. Smiles,15 Stuart J. McGurnaghan,16 Jani K. Haukka,5,6,7 Valma Harjutsalo,5,6,7,17 Eoin P. Brennan,9 Natalie van Zuydam,18,19 Emma Ahlqvist,20 Ross Doyle,9 Tarunveer S. Ahluwalia ,21 Maria Lajer,21 Maria F. Hughes,9 Jihwan Park,13 Jan Skupien,15 Athina Spiliopoulou,11 Andrew Liu,22 Rajasree Menon,14,23 Carine M. Boustany-Kari,24 Hyun M. Kang,23,25 Robert G. Nelson,26 Ronald Klein,27 Barbara E. Klein,27 Kristine E. Lee ,27 Xiaoyu Gao,28 Michael Mauer,29 Silvia Maestroni,30 Maria Luiza Caramori,29 Ian H. de Boer ,31 Rachel G. Miller,32 Jingchuan Guo ,32 Andrew P. Boright,12 David Tregouet,33,34 Beata Gyorgy,33,34 Janet K. Snell-Bergeon,35 David M. Maahs,36 Shelley B. Bull ,37 Angelo J. Canty,38 Colin N.A. Palmer,39 Lars Stechemesser,40 Bernhard Paulweber,40 Raimund Weitgasser,40,41 Jelizaveta Sokolovska,42 Vita Rovıte,43 Valdis Pırags, 42,44 Edita Prakapiene,45 Lina Radzeviciene,46 Rasa Verkauskiene,46 Nicolae Mircea Panduru,6,47 Leif C.
    [Show full text]
  • Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?
    Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Science (Cancer Biology) Aneuploidy: Using genetic instability to preserve a haploid genome? Submitted by: Ramona Ramdath In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Science Examination Committee Signature/Date Major Advisor: David Allison, M.D., Ph.D. Academic James Trempe, Ph.D. Advisory Committee: David Giovanucci, Ph.D. Randall Ruch, Ph.D. Ronald Mellgren, Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: April 10, 2009 Aneuploidy: Using genetic instability to preserve a haploid genome? Ramona Ramdath University of Toledo, Health Science Campus 2009 Dedication I dedicate this dissertation to my grandfather who died of lung cancer two years ago, but who always instilled in us the value and importance of education. And to my mom and sister, both of whom have been pillars of support and stimulating conversations. To my sister, Rehanna, especially- I hope this inspires you to achieve all that you want to in life, academically and otherwise. ii Acknowledgements As we go through these academic journeys, there are so many along the way that make an impact not only on our work, but on our lives as well, and I would like to say a heartfelt thank you to all of those people: My Committee members- Dr. James Trempe, Dr. David Giovanucchi, Dr. Ronald Mellgren and Dr. Randall Ruch for their guidance, suggestions, support and confidence in me. My major advisor- Dr. David Allison, for his constructive criticism and positive reinforcement.
    [Show full text]
  • GWAS for Meat and Carcass Traits
    G3: Genes|Genomes|Genetics Early Online, published on July 11, 2019 as doi:10.1534/g3.119.400452 GWAS for meat and carcass traits using imputed sequence level genotypes in pooled F2- designs in pigs Clemens Falker-Gieske,*,1,2 Iulia Blaj,†,2 Siegfried Preuß,‡ Jörn Bennewitz,‡ Georg Thaller,† Jens Tetens*,§ *Department of Animal Sciences, Georg-August-University, 37077 Göttingen, Germany. †Institute of Animal Breeding and Husbandry, Kiel University, 24118 Kiel, Germany. ‡Institute of Animal Husbandry and Breeding, University of Hohenheim, 70599 Stuttgart, Germany. §Center for Integrated Breeding Research, Georg-August-University, 37077 Göttingen, Germany. 1 © The Author(s) 2013. Published by the Genetics Society of America. Running title: Sequence level GWAS in pooled F2 pigs Keywords Genome wide association study Whole genome sequencing Imputation Meat, carcass, and production traits Variant calling 1Corresponding author: Clemens Falker-Gieske, Georg-August-University Goettingen, Department of Animal Sciences, Division Functional Breeding, Burckhardtweg 2, 37077 Goettingen, (+49) 551-39-23669 2contributed equally. 2 ABSTRACT In order to gain insight into the genetic architecture of economically important traits in pigs and to derive suitable genetic markers to improve these traits in breeding programs, many studies have been conducted to map quantitative trait loci. Shortcomings of these studies were low mapping resolution, large confidence intervals for quantitative trait loci-positions and large linkage disequilibrium blocks. Here, we overcome these shortcomings by pooling four large F2 designs to produce smaller linkage disequilibrium blocks and by resequencing the founder generation at high coverage and the F1 generation at low coverage for subsequent imputation of the F2 generation to whole genome sequencing marker density.
    [Show full text]
  • SUPPLEMENTARY METHODS DNA Sequencing and Variant
    Supplementary material J Med Genet SUPPLEMENTARY METHODS DNA sequencing and variant identification Genomic DNA was isolated from peripheral blood lymphocytes following standard procedures. Subsequently, exome enrichment was performed using the Agilent SureSelect Human All Exome V5 kit according to the manufacturer’s protocols. Exome sequencing was performed on an Illumina HiSeq system by BGI Europe (Copenhagen, Denmark). Read mapping along the hg19 reference genome (GRCh37/hg19) and variant calling were performed using BWA V.0.78(1) and GATK HaplotypeCaller V.3.3(2). A coverage of >20 reads was reached for 85.1% to 97.8% of the enriched regions. For variant annotation an in-house developed annotation and variant evaluation pipeline was used. For sequencing data of family W97-056, CNV detection was performed using CoNIFER V.0.2.2.(3) Genome sequencing was performed by BGI (Hong Kong, China) on a BGISeq500 using a 2x 100 bp paired end module, with a minimal median coverage of 30-fold per genome. Structural variants were called using Manta V.1.1.0(4) and CNVs using Control-FREEC.(5) Variants were validated and visualized using the IGV Software (V.2.4).(6) In the index case of family W08-1421, targeted DNA sequencing was performed using MIP sequencing.(7) MIPs were designed covering exons and exon-intron boundaries of a panel of 89 HL genes (Supplementary Table 6). Sequencing and data analysis were performed as previously described.(8) For each targeted region, an average coverage of 420 reads was obtained. A coverage of >20 reads was reached for 85.4% of the MIPs.
    [Show full text]
  • Genome-Wide Association and Trans-Ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND)
    RESEARCH ARTICLE Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND) Sudha K. Iyengar1☯*, John R. Sedor2,3☯*, Barry I. Freedman4☯*, W. H. Linda Kao5†, Matthias Kretzler6, Benjamin J. Keller6, Hanna E. Abboud7†, Sharon G. Adler8, Lyle G. Best9, Donald W. Bowden10, Allison Burlock6, Yii-Der Ida Chen11, Shelley A. Cole12, Mary E. Comeau13, Jeffrey M. Curtis14, Jasmin Divers13, Christiane Drechsler15, Ravi Duggirala12, Robert C. Elston1, Xiuqing Guo11, Huateng Huang16, Michael Marcus Hoffmann17, Barbara V. Howard18, Eli Ipp19, Paul L. Kimmel20, Michael J. Klag21, William C. Knowler14, Orly F. Kohn22, Tennille S. Leak6, David J. Leehey23, Man Li24, Alka Malhotra14, Winfried März25, Viji Nair6, Robert G. Nelson14, Susanne B. Nicholas26, Stephen J. O’Brien27, Madeleine V. Pahl28, Rulan S. Parekh29, Marcus G. Pezzolesi30, Rebekah S. Rasooly31, Charles N. Rotimi32, Jerome I. Rotter11, Jeffrey R. Schelling2, Michael F. Seldin33, Vallabh O. Shah34, Adam M. Smiles35, Michael W. Smith36, Kent D. Taylor11, Farook Thameem37¤, Denyse P. Thornley-Brown38, Barbara J. Truitt1, OPEN ACCESS Christoph Wanner39, E. Jennifer Weil14, Cheryl A. Winkler40, Philip G. Zager41, Robert P. Igo, Jr1‡, Robert L. Hanson14‡, Carl D. Langefeld11‡, Family Investigation of Citation: Iyengar SK, Sedor JR, Freedman BI, Kao Nephropathy and Diabetes (FIND)¶ WHL, Kretzler M, Keller BJ, et al. (2015) Genome- Wide Association and Trans-ethnic Meta-Analysis for 1 Department of Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, Ohio, Advanced Diabetic Kidney Disease: Family United States of America, 2 Departments of Medicine, Case Western Reserve University, Cleveland, Ohio, Investigation of Nephropathy and Diabetes (FIND).
    [Show full text]
  • Meta-Analysis of Gene Signatures and Key Pathways Indicates
    www.nature.com/scientificreports OPEN Meta‑analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo‑resistance in AML Parastoo Modarres1, Farzaneh Mohamadi Farsani1,3, Amir Abas Nekouie2 & Sadeq Vallian1* The pathways and robust deregulated gene signatures involved in AML chemo‑resistance are not fully understood. Multiple subgroups of AMLs which are under treatment of various regimens seem to have similar regulatory gene(s) or pathway(s) related to their chemo‑resistance phenotype. In this study using gene set enrichment approach, deregulated genes and pathways associated with relapse after chemotherapy were investigated in AML samples. Five AML libraries compiled from GEO and ArrayExpress repositories were used to identify signifcantly diferentially expressed genes between chemo‑resistance and chemo‑sensitive groups. Functional and pathway enrichment analysis of diferentially expressed genes was performed to assess molecular mechanisms related to AML chemotherapeutic resistance. A total of 34 genes selected to be diferentially expressed in the chemo‑ resistance compared to the chemo‑sensitive group. Among the genes selected, c-Jun, AKT3, ARAP3, GABBR1, PELI2 and SORT1 are involved in neurotrophin, estrogen, cAMP and Toll‑like receptor signaling pathways. All these pathways are located upstream and regulate JNK signaling pathway which functions as a key regulator of cellular apoptosis. Our expression data are in favor of suppression of JNK pathway, which could induce pro‑apoptotic gene expression as well as down regulation of survival factors, introducing this pathway as a key regulator of drug‑resistance development in AML. Acute myeloid leukemia (AML) is one of the most aggressive, life-threatening hematological malignancies char- acterized by uncontrolled proliferation of abnormal diferentiated and nonfunctional myeloid precursor cells1.
    [Show full text]
  • Temporal Proteomic Analysis of HIV Infection Reveals Remodelling of The
    1 1 Temporal proteomic analysis of HIV infection reveals 2 remodelling of the host phosphoproteome 3 by lentiviral Vif variants 4 5 Edward JD Greenwood 1,2,*, Nicholas J Matheson1,2,*, Kim Wals1, Dick JH van den Boomen1, 6 Robin Antrobus1, James C Williamson1, Paul J Lehner1,* 7 1. Cambridge Institute for Medical Research, Department of Medicine, University of 8 Cambridge, Cambridge, CB2 0XY, UK. 9 2. These authors contributed equally to this work. 10 *Correspondence: [email protected]; [email protected]; [email protected] 11 12 Abstract 13 Viruses manipulate host factors to enhance their replication and evade cellular restriction. 14 We used multiplex tandem mass tag (TMT)-based whole cell proteomics to perform a 15 comprehensive time course analysis of >6,500 viral and cellular proteins during HIV 16 infection. To enable specific functional predictions, we categorized cellular proteins regulated 17 by HIV according to their patterns of temporal expression. We focussed on proteins depleted 18 with similar kinetics to APOBEC3C, and found the viral accessory protein Vif to be 19 necessary and sufficient for CUL5-dependent proteasomal degradation of all members of the 20 B56 family of regulatory subunits of the key cellular phosphatase PP2A (PPP2R5A-E). 21 Quantitative phosphoproteomic analysis of HIV-infected cells confirmed Vif-dependent 22 hyperphosphorylation of >200 cellular proteins, particularly substrates of the aurora kinases. 23 The ability of Vif to target PPP2R5 subunits is found in primate and non-primate lentiviral 2 24 lineages, and remodeling of the cellular phosphoproteome is therefore a second ancient and 25 conserved Vif function.
    [Show full text]